NCT05328167View on ClinicalTrials.gov

Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Intrahepatic Cholangiocarcinoma
Interventions
DRUG

Perflutren Protein-Type A Microspheres

Given IV

PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

Trial Locations (1)

19107

RECRUITING

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Thomas Jefferson University

OTHER